Clinical Trial Update: Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating spironolactone as an aldosterone antagonist in adults with heart failure with preserved ejection fraction was completed, and results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• Aldactone (spironolactone)

Snippet

Sponsor: Carelon Research | Conditions: Cardiovascular Diseases, Heart Diseases | Phase 3 | Status: COMPLETED | Results posted: 2015-03-02